Chairman Barry Epling will now spend more time on R&D
Las Vegas, Florida-based nutraceuticals research and development company BioAdaptives has appointed Christopher Hall as President. He also takes the additional titles of Chief Executive, Chief Financial Officer, and Secretary.
Barry Epling, Chairman of the Board of Directors, who previously led the company, will now spend more of his time on research and development of new products.
Hall has been an executive within the nutraceutical products industry since 2006 and a serial entrepreneur for more than 20 years. He began his career in 1978 with AT&T as a Finance and Operations Manager.
BioAdaptives now has four products ready for the market with an additional product expected to be ready for delivery in the second quarter.
The four products: PrimiCell, a stem cell activator; PrimiLive, which provides stress-relief and energy without stimulants; Equine Regen Plus, a multi-faceted equine wellness stem cell activating product for performance horses; and Canine Regen, a supplement for canine stem cell health and wellness.
A fifth product, PrimiTrim, is a natural weight management product.
Additional products, which are currently being tested, will follow later in the year.